← Back to directory

Cihan Ay

Researcher Next ID · RN-040019

Researcher · Medicine

University of North Carolina at Chapel Hill

Chapel Hill, Austria

Accepting doctoral researchersFunding unknown
Works count
609
Citation count
21,287
H-index
70
i10-index
278

Research interests

Medicine
Venous Thromboembolism Diagnosis and Management
Blood Coagulation and Thrombosis Mechanisms
Platelet Disorders and Treatments
Hemophilia Treatment and Research
Atrial Fibrillation Management and Outcomes

Publications

  • Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    Annals of Oncology · 2023 · 10.1016/j.annonc.2022.12.014

  • Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life

    Respiration · 2022 · 10.1159/000522118

  • 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00160-7

  • Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH

    Hämostaseologie · 2021 · https://doi.org/10.1055/a-1469-7481

  • Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab816

  • American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

    Blood Advances · 2021 · https://doi.org/10.1182/bloodadvances.2020003442

  • Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis

    Research and Practice in Thrombosis and Haemostasis · 2020 · 10.1002/rth2.12439

  • Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

    Blood · 2020 · 10.1182/blood.2020007878

  • Venous thromboembolism in cancer patients: a population-based cohort study

    Blood · 2020 · https://doi.org/10.1182/blood.2020007338

  • 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30336-5

  • A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

    The Lancet Haematology · 2018 · 10.1016/s2352-3026(18)30063-2

  • Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients

    Journal of Thrombosis and Haemostasis · 2018 · 10.1111/jth.13951

  • Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH

    Journal of Thrombosis and Haemostasis · 2018 · 10.1111/jth.14015

  • Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

    Blood · 2017 · 10.1182/blood-2016-06-720714

  • Cancer-associated venous thromboembolism: Burden, mechanisms, and management

    Thrombosis and Haemostasis · 2016 · https://doi.org/10.1160/th16-08-0615

  • Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants

    Thrombosis Research · 2015 · 10.1016/j.thromres.2015.07.011

  • Biomarkers for prediction of venous thromboembolism in cancer

    Blood · 2013 · 10.1182/blood-2013-04-460147

  • High D-dimer levels are associated with poor prognosis in cancer patients

    Haematologica · 2012 · 10.3324/haematol.2011.054718

  • Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

    Journal of Thrombosis and Haemostasis · 2012 · 10.1111/j.1538-7836.2012.04754.x

  • Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

    Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.32.8294

  • Prediction of venous thromboembolism in cancer patients

    Blood · 2010 · https://doi.org/10.1182/blood-2010-02-270116

  • Biomarkers and Venous Thromboembolism

    Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 10.1161/atvbaha.108.182188

  • High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

    Journal of Thrombosis and Haemostasis · 2009 · 10.1111/j.1538-7836.2009.03680.x

  • D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

    Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.21.7752

  • High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

    Blood · 2008 · 10.1182/blood-2008-02-142422

Current projects

    No projects listed.